November 1994

Bone Modeling Alteration in Premature Infants

Author Affiliations

Clinica Pediatrica III University of Milan
via Olgettina 60 20132 Milan, Italy

Arch Pediatr Adolesc Med. 1994;148(11):1215-1217. doi:10.1001/archpedi.1994.02170110101021

Osteopenia is a well-recognized disorder of bone metabolism among premature infants.1 -6 Its cause is thought to be complex, with dietary deficiency being a major causative factor. Impairment of bone modeling has also been hypothesized, but extensive studies in infants have not been possible not only because of the invasive procedures required but also because of the lack of specificity of the widely used biochemical indexes of bone formation and resorption. Recently, new specific biochemical markers of bone modeling became available.

Type I collagen accounts for more than 90% of the organic bone matrix.7 It is derived from a larger protein, type I procollagen, which has propeptide extensions at both ends of the molecule.8 Procollagen type I carboxyterminal propeptide (PICP), a trimeric globular protein, is removed by specific proteinases before collagen molecules are assembled into fibers. Procollagen propeptides are released into circulation in a stoichiometric ratio of

First Page Preview View Large
First page PDF preview
First page PDF preview